In 2022, an estimated 11·7 million people were affected by chronic hepatitis C virus (HCV) infection in the WHO Eastern Mediterranean Region (EMR), accounting for 23% of the global burden.1 This ...

Overview of Hepatitis C Drug MarketThe global Hepatitis C Drug Market is valued at USD 7.95 Billion in 2024 and is projected ...